• SCREENING

    Blood biomarker hPG80 shows promise for CRC screening and treatment monitoring

    A scoping review of five studies encompassing 2,692 participants found that plasma hPG80 was significantly overexpressed in CRC patients compared to controls and decreased significantly after surgery, though optimal thresholds and stage-specific correlations remain to be established. (Biomarker Insights)